Summary With an experimental model of spontaneous lung metastases in immunosuppressed newborn rats, seven clones and variants with different metastatic potential and gangliosides expression were derived from a single parental human melanoma cell line M4Be. The cellular radiosensitivity of M4Be and its seven sublines was estimated using an in vitro colony assay. The total amount of gangliosides in M4Be and its seven sublines was determined by cell extraction and thin-layer chromatography, while the expression of GD3 gangliosides was estimated by flow cytometry with a monoclonal antibody. The radiation-cell survival curves of most clones and variants derived from M4Be showed a zero dose extrapolation clearly lower than 100%, suggesting that two populations of cells of very different radiosensitivity coexist within each of these clones and variants. Although the proportion of radiosensitive cells could be estimated from the shape of the survival curve, its radiosensitivity is too high to be properly evaluated by the colony assay. The eight survival curves differ essentially in the proportion of radiosensitive cells -which varied from 0% to 40% among M4Be and its seven sublines -whereas the cellular radiosensitivity of the radioresistant population was similar among them. The metastatic potential in vivo of M4Be and its seven sublines was not significantly related to the cellular radiosensitivity of their corresponding radioresistant population, but significantly increased with the fraction of radiosensitive cells. This relationship is valid only when the highly metastatic cells are cultured for no more than five passages in vitro as the fraction of radiosensitive cells is rapidly lost during subcultures. The relationship remains valid in vivo as metastatic melanoma-bearing newborn rats whole body irradiated with 20 cGy show no lung metastasis compared with controls. The radiosensitive cell fraction is inversely correlated with both the total ganglioside content (r= 0.84, P < 0.02) and the number of cells positively labelled with the monoclonal antibody directed to GD3 (r= 0.92, P < 0.001). The incubation of a radiosensitive clone with the exogenous bovine brain ganglioside GM1 significantly increases the proportion of radioresistant cells and suppresses its metastatic potential, while the inhibition of the endogenous gangliosides synthesis in the radioresistant cell line M4Be increases the proportion of radiosensitive cells. This study provides a possible explanation for the correlation between the metastatic potential and the proportion of radiosensitive cells within the seven sublines derived from a single parental human melanoma cell line.
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Keywords: human melanoma clone; spontaneous metastatic potential in vivo; radiosensitivity in vitro; biphasic survival curve; proportion of radiosensitive cells in vitro; gangliosides At the time of the primary tumour diagnosis, up to 60% of patients may have microscopic and/or clinically evident metastases (Liotta, 1990) . The efficacy of radiotherapy of metastases is size dependent i.e. the smaller the tumour size, the higher the radiocurability; this relationship has been demonstrated both in clinical studies (Fletcher, 1963) and in experimental studies (Courdi and Malaise, 1980) . However, tumours, even small ones, are heterogeneous with regard to radiosensitivity in vitro as radioresistant and radiosensitive clonal populations are coexisting in the tumour cell lines (Alexander, 1961; Gridna et al, 1975; Hill et al, 1979; Leith et al, 1982; Welch et al, 1983; Jenkins et al, 1986; Yang et al, 1991; Buronfosse et al, 1994; Thomas et al, 1995a) ; this feature may be unstable and could change with culture passages in vitro either towards more radioresistant cells, as observed with some murine melanoma clones (Hill et al, 1979) and the MTLn3 clone isolated from the rat mammary adenocarcinoma 13762NF (Welch et al, 1983) , or towards more radiosensitive cells, as observed with the MTC clone isolated from 13762NF (Welch et al, 1983) . The fact that tumours contain subpopulations of cells of different metastatic potential has also been observed (Fidler, 1973) , although these subpopulations change in their metastatic properties with passages in vitro (Neri and Nicolson, 1981) . It is likely that, in tumours, the fraction of radioresistant cells together with the ability of tumours to generate metastases are major factors of failure in radiotherapy. As ionizing radiation is a strong mutagenic agent, it is believed that radiotherapy may allow the radioresistant tumour cells to make their last mutation during treatment, hence leading to the development of metastases. As far as we are aware, this concept Table 1 The total ganglioside content, the number of cells positively labelled with the monoclonal antibody directed to the surface disialoganglioside GD3, the plating efficiency in vitro and the spontaneous metastatic potential in the immunosuppressed newborn rats of the human melanoma cell line M4Be and the seven sublines derived from M4Be (1996) . bData from Thomas et al (1995b) . cThe number of rats with lung metastasis/the number of rats injected (reported from Thomas et al 1995a). dThe median is significantly higher than that obtained with clone 1 (P <0.05). eThe median is significantly higher than that obtained with subvariant 1-(P<0.05). Statistical analysis was done using the non-parametric Wilcoxon test. ND, not determined.
has never been verified experimentally and no relationship has been established so far between the metastatic potential of tumour cells in vivo and their radioresistance in vitro (see review by Suit et al, 1994) . However, this relationship was mainly sought among tumour cell lines. Within a given tumour cell line, in contrast, we have observed recently that these two independent biological parameters appear to be correlated provided that the highly metastatic cells are cultured for no more than five passages in vitro (Thomas et al, 1995a) . We observed that the higher the metastatic potential of the seven sublines derived from a single parental human melanoma cell line (M4Be), the higher their cellular radiosensitivity, as estimated using an in vitro colony assay. To find a possible explanation for this relationship, we have characterized the sublines derived from M4Be by their surface gangliosides expression (ganglioside is the trivial name for sialic acid-bearing glycolipids). Indeed, the data in the literature suggest that, for the highly radiosensitive cells, molecular changes in the plasma membrane could be involved in ionizing radiation-induced cell death (Ramakrishnan et al, 1993) and that surface glycolipids may be involved (Kono et al, 1990; Haimovitz-Friedman et al, 1994) . The expression of these surface molecules changes dramatically in many cells during the oncogenic transformation, suggesting a specific role for membrane glycolipids in the regulation of cell growth and cellular interaction (Hakomori, 1981) . Although the gangliosides are ubiquitous plasma membrane molecules of essentially all the eukaryotic cells, the research of their biological functions is a field still in its infancy. Gangliosides which are shed by tumour cells into the serum may suppress the cellular immune response in vivo, thereby facilitating the tumour progression (Li et al, 1995) . The results from our laboratory suggest that the deficiency of the gangliosides synthesis at the cell surface of some sublines derived from the M4Be human melanoma cell line is associated with both a high spontaneous metastatic potential in vivo (Thomas et al, 1995b; Zebda et al, 1995) and high radiosensitivity in vitro (Thomas et al, 1996) . This study provides evidence that the gangliosides may be a possible molecular factor linking the proportion of radiosensitive cells detected in some sublines of the human melanoma cell line M4Be to their metastatic potential in vivo.
MATERIALS AND METHODS Human melanoma cells
The clone IC8 was selected from the human-characterized melanoma cell line M4Be that was established from a patient's lymph node melanoma metastasis (Jacubovich and Dore, 1979) . The selection and cloning methods have been described previously . The variant Tlp26 was established in culture after two direct successive transplantations of the M4Be tumours into immunosuppressed newborn rats (Bailly et al, 1993) . The variant Tlp26 is itself heterogeneous, containing two populations of cells that were separated by flow cytometry for their ability to bind the PNA lectin (peanut agglutinin lectin); the PNA recognizes specific glycoproteins at the cell surface, and the binding is higher for the subvariant Tlp26R than the subvariant Tlp26L; the metastatic potential of the subvariant Tlp26R is significantly higher than that of the subvariant T1p26L (Zebda et al, 1994 ; Table 1 ). The clones TlCll, T1C6 and T1C3 were obtained by limiting dilution from the Tlp26 variant. With the exception of the T1C6 and TICI1 clones, the derivation of the variants and clones from the M4Be cell line has been previously described (Zebda et al, 1994) . The common origin of all these cell sublines is attested by their karyotype and by their sharing common marker chromosomes with the parental cell line M4Be; the cells appeared hypertriploid, showing quite similar modal numbers (around 70) (Bailly and Dore, 1992) . For sake of clarity, they are referred to below as clone 1 (IC8), clone 2 (T ICI 1), clone 3 (TIC6), clone 4 (T1C3), variant 1 (Tlp26), subvariant 1-(Tlp26L), subvariant 1+ (Tlp26R) and M4Be (parental cell line). The cell cultures obtained from the seven clones and variants were frozen a few passages after their isolation.
Lung spontaneous metastasis assay
The M4Be cell line and the seven clones and variants have all been characterized for their ability to give low, intermediate and high numbers of spontaneous metastases in the lungs of the immunosuppressed newborn rats (Table 1 ). The lung metastatic potential was measured using a standardized protocol previously described . Briefly, the cells taken from the frozen stock were cultured for at least one passage and, at day 0, Wistar rats not older than 24 h were injected subcutaneously (SC) with 106 cells in 0.1 ml of phosphate-buffered saline (PBS) in the thorax area, together with an optimal dose of anti-thymocyte serum (ATS) in the dorsum (0.05 ml). The ATS injection was repeated on days 2, 7 and 14. All the sublines derived from M4Be, whatever their metastatic potential, produced SC tumours that were growing at the injection site. The animals were sacrificed on day 21, and the number of rats with lung metastasis vs the number of rats injected was determined. The number of lung nodules was scored, and the median lung nodules per rat was calculated. The median was chosen to take into account the total number of rats injected, even those without lung metastases as it was observed that in some cases, the probability for a rat to have no metastasis was not negligible (Table 1 ). The absence of occult metastases in the lungs with no visible metastases was confirmed by a histological examination. All experiments were performed according to the national regulations for animal welfare.
Expression of the cell surface gangliosides
The total ganglioside content in the M4Be cell line and its seven sublines was determined by cell extraction and thin layer chromatography as previously described (Thomas et al, 1996) . The expression of the disialoganglioside GD3 in the M4Be melanoma cell line and its seven sublines were determined by flow cytometry using a method already published (Thomas et al, 1995b (Thomas et al, , 1996 . Briefly, after 4 days of culture, the early confluent cells were detached with 0.02% EDTA; the number of cells GD3 positive in 106 cells was detected by immunofluorescence, using a primary murine monoclonal antibody 4F6 (IgG3) directed to GD3 (45 min of incubation at ambient temperature) and a mouse total immunoglobulin (second antibody) coupled to fluroscein (30 min of incubation at ambient temperature). The cells were rinsed with PBS after the incubation with the primary antibody and the secondary antibody coupled to fluoroscein. The antibody 4F6 was produced after immunization of the Balb/C mice with GD3 purified from the human melanoma tumours and fusion with the SP2 mouse myeloma. As shown by ELISA (Portoukalian et al, 1991) and TLC immunostaining (Portoukalian and Bouchon, 1986) , the antibody reacts with GD3, O-acetyl GD3 and GTIa but not with GM3, GD2 and GT3 (C Pinatel and J Portoukalian, unpublished results). A flow cytometer FACScan was used to compare the number of fluorescent cells detected in PBS with no primary 4F6 antibody and the second antibody coupled to fluoroscein (control) to the number of fluorescent cells detected in the presence of the primary 4F6 antibody and the second antibody coupled to fluoroscein. Two thousand cells were analysed.
Irradiation and the cell radiosensitivity measurement
The radiosensitivity experiments were performed with the cells obtained from the frozen stock; the cells were not cultured more than 3 months after the cell defrost, i.e. no more than 15 passages. The cells were cultured as monolayers in plastic flasks (Coming) and maintained at 37°C in an atmosphere of 5% carbon dioxide in air. The cells were grown in McCoy 5A medium (Gibco), supplemented with 10% decomplemented fetal calf serum (Gibco), 1% antibiotics (penicillin, streptomycin), 1% Hepes 1M and 1% glutamine. The cultures were routinely checked and found free of mycoplasma. In the growth phase, the doubling time of the clones and variants were about 24 h without any apparent relationship with the metastatic ability (Bailly et al, 1993) . The plating efficiencies of clones and variants are reported in Table 1 . The clones 1 and 4, the variants 1 and the subvariants 1-and I + were irradiated with y-rays from a 6 Co source that provided a mean dose rate of 0.58 ± 0.01 Gy min-' to the culture flasks. The clones 2 and 3 as well as the M4Be cell line were irradiated with high energy X-rays produced from a 5-MV linear accelerator that provided a mean dose rate of 4 Gy min-' to the culture flasks. The dose rates were checked with an ionization chamber, and the homogeneity of the dose over the irradiation field was verified with radiographic film (± 3%). Although the source of ionizing radiation and the dose rate was changed during the course of these experiments, no effect on the radiosensitivity is expected. Indeed, no significant differences were found in the radiosensitivity of human cell lines for dose rates in this range [e.g. for Hela cells with dose rate varying from 7 Gy min-' to 0.45 Gy min-' (Hall, 1972) and for five fibroblasts with dose rate varying from 1 Gy min-' to 0.5 Gy min-' (Badie et al, 1996) ]. The experiments were carried out with the early confluent cultures, i.e. at a time when about 80% of the cells are blocked in the G, phase. The cells were detached with 0.05% trypsin-0.02% EDTA in PBS, and the single cell suspensions were seeded on 25 cm2 plastic flasks (Coming) at cell numbers appropriate for the colony formation. Two flasks were used at each radiation dose and the number of radiation doses was eleven varying from 5 cGy to 7 Gy. Twenty-four hours after plating, the cultures were irradiated after the electronic equilibrium and at room temperature under aerobic conditions. In our experimental conditions, i.e. cells plated at low density and irradiated 24 h after plating, the influence of cell multiplicity (the number of cells per potential colony-forming unit) on the calculation of cellular radiosensitivity is negligible. After 2 weeks of incubation without changing the medium in an atmosphere of 5% carbon dioxide in air, the colonies were rinsed with PBS, fixed and stained with a mixture of alcohol 20%-crystal violet (1: 1, by volume). The colonies containing more than 50 cells were scored, and the cell survival curves were established. The surviving fraction S(D), for a dose D, was calculated as the plating efficiency of the irradiated cells over that of the unirradiated cells; the plating efficiency is the number of colonies counted over the number of cells inoculated at day 0.
Analysis of survival curves
The model
The shapes of most of the survival curves of the clones and variants derived from the human melanoma cell line M4Be clearly suggest the existence of two populations of cells with very different radiosensitivity. The survival curves are adequately described by a sum of linear-quadratic terms, an extra parameter (X) being (1) where xRPR and ocsps are the parameters of the radiosensitivity of the two radioresistant and radiosensitive populations respectively; X is the proportion of radioresistant cells. This model was found to be satisfactory, but the radiosensitivity of the radiosensitive population is too high to be properly estimated with the in vitro colony assay, and insufficient data were available in the very low dose range (i.e. lower than 0.12 Gy). The model was therefore simplified:
The mean inactivation dose, equal to the area under the survival curve plotted in linear coordinates, is used as an index of the radiosensitivity and calculated by the numerical integration of S(D). The radiosensitivity of the whole population, as well as that of the resistant part, was evaluated following the method proposed by Fertil et al (1984) . The mean inactivation dose of the total population (DT) was calculated using equation 2, whereas the mean inactivation dose of the radioresistant population (DR) was calculated using the same equation with k = 1.
Statistical analysis
The relationship between the proportion of radioresistant cells (X) and the metastatic potential was tested using the analysis of variance (ANOVA). Puck and Marcus (1956) , most of the in vitro human cell-survival curves described in the literature do not display such a feature, several multiphasic curves have already been established with mammary adenocarcinoma clones (Welch et al, 1983) , variants of CHO cells (Denekamp et al, 1989) , fibroblasts from skin biopsies (e.g. Loeffler et al, 1990 ), a glioblastoma cell line (Allalunis-Turner et al, 1993), a soft-tissue sarcoma cell line (Dahlberg et al, 1993) , lymphocytes from the blood of healthy volunteers (Uzawa et al, 1994 ) and endometrial cancer cell lines (Rantanen et al, 1995) . Apoptosis has been proposed as a possible mechanism in producing the high radiosensitivity of the primary human uroepithelium cells at low radiation doses of Cobalt-60 gamma rays (Mothersill et al, 1995) .
The proportion of radiosensitive cells in the metastatic clones is reduced rapidly during the in vitro (Figure 1 ). It seems that, for some sublines, the radioresistance increases during the culture passage in vitro. Such a drift has already been reported with murine melanoma clones (Hill et al, 1979 ) and a rat mammary adenocarcinoma clone MTLn3 (Welch et al, 1983) . To investigate this phenomenon, radiosensitivity parameters were evaluated for each experiment. However, important variations were expected as three parameters had to be estimated from a small set of data. For example, coefficients of variation of 34%, 26% and 42% for the mean inactivation dose of the total population P)T)' the mean inactivation dose of the radioresistant population (DR) and the proportion of radioresistant cells (X), respectively, were obtained with the five separate experiments from clone 4 ( Figure 1 ). The parameters X and DR were plotted against the number of passages after the cell defrost for the seven clones and variants ( Figure 2 ). The drift of X toward unity is particularly obvious for the highly metastatic cells (clone 4, variant 1 and subvariant 1+), whereas . appeared relatively stable and close to one for the cells with low metastatic potential (clone 1) and intermediate metastatic potential (clones 2 and 3, subvariant 1-). Indeed, during the 15 passages undergone by clone 4 in the culture after the cell defrost, x varied from 27% to 100% while it remained around 100% in clone 1 during the 10 passages ( Figure 2A ). In contrast, during the in vitro subcultures after the cell defrost, no systematic variation in the radiosensitivity of the radioresistant population, as estimated from DR could be detected ( Figure 2B ).
To obtain an acceptable estimation of the radiosensitivity after the cell defrost, only the data measured after no more than five passages in vitro (two experiments) were used for establishment of the survival curve.
The survival curves vary from one subline to another
The survival data obtained with clones 1 and 4 are presented in Figure 3A . Clone 4 is much more radiosensitive than clone 1, and the radiosensitivity of the parental cell line M4Be is similar to that obtained with clone 1 (Figure 3A) . Low Medium
High
Metastatic potential Figure 4 The variations of both the proportion of radioresistant cells in vitro (x) and the mean inactivation dose of the radioresistant population (DR) with the metastatic potential in vivo of the seven clones and variants derived from the human melanoma cell line M4Be. The 95% confidence intervals are represented. A significant correlation exists between X and the metastatic potential: the higher the value of X, the lower the metastatic potential (P < 0.006, ANOVA analysis) with M4Be and clone 4 ( Figure 3B ). Figure 3C shows the survival curves obtained from variant 1 and the two subvariants 1+ and 1-; the two subvariants were separated by flow cytometry for their ability to bind PNA, a lectin recognizing specific glycoproteins at the cell surface (Zebda et al, 1994 ). The subvariant 1+, which binds more PNA than the subvariant 1-, is much more radiosensitive, while an intermediate response to radiation is observed for variant 1. Examination of the parameter values of the eight cellsurvival curves (DT and X) confirms that the clones and variants derived from the M4Be parental cell line differ in their radiosensitivity (Table 2) . Clone 1, subvariant 1-and the M4Be cell line are the most radioresistant; clone 4 and subvariant 1+ are the most radiosensitive, while clones 2 and 3 and variant 1 show an intermediate response to radiation. This result is similar to previous observations showing the clonal variation in the radiosensitivity inside tumour cell lines obtained from lymphoma (Alexander, 1961) , fibrosarcoma (Grdina et al, 1975) , melanomas (Hill et al, 1979; Thomas et al, 1995a) , the stomach (Jenkins et al, 1986) , the colon (Leith et al, 1982) , the breast (Dewyngaert et al, 1981; Welch et al, 1983) and glioblastomas (Yang et al, 1991; Buronfosse et al, 1994) .
The survival curves of the seven clones and variants differ essentially by the proportion of radioresistant cells
The proportions of radioresistant cells (X) were: 1.1, 1.09 and 0.98, respectively, for the M4Be parental cell line, clone 1 and subvariant 1-; 0.93, 0.91 and 0.82, respectively, for clones 2, 3 and variant 1; 0.69 and 0.59, respectively, for subvariant 1+ and clone 4. This variation is characterized by a coefficient of variation (CV) of 20% (Table 2 ). In contrast, in the M4Be cell line and the seven sublines derived from M4Be, the variation of the radiosensitivity of the radioresistant population as measured byDR can be considered as non-significant, being typical of results based only on two experiments (CV = 9%, Table 2 ).
Although the proportion of radiosensitive cells is known (1-X), their radiosensitivity is too high to be properly estimated using the in vitro colony assay. However, considering the survival at the first dose investigated, the mean inactivation dose of the radiosensitive population (Ds) could not be higher than 0.2 Gy. This observation is consistent with the hypersensitivity that was observed in the initial part of the survival curve of a human tumour cell line; depending on the model used to analyse the data, Ds varied between 0.9 Gy and 0.04 Gy (Lambin et al, 1993) . Thus, the variation in the radiosensitivity of the seven clones and variants derived from the M4Be melanoma cell line essentially results from difference in the proportion of radioresistant cells. It should be pointed out that a similar behaviour has already been described for the variants of CHO normal cells (Denekamp et al, 1989) . Using a similar survival-curve model, they found in several cell variants a fraction of radioresistant cells varying from 0.4% to 12% of the total population, and hence these authors could state that 'the reported difference (in their radiosensitivity) results from the variability in the fraction of cells expressing radioresistance'.
The metastatic potential of the human melanoma sublines is related to their radiosensitive cell fraction but not to the radiosensitivity of their radioresistant cell fraction As reported in Table 1 , the seven clones and variants derived from M4Be have different metastatic capacity. Clone 1 and the M4Be cell line have the lowest metastatic potential whereas clone 4, variant 1 and subvariant 1+ are highly metastatic. Clones 2 and 3 and subvariant 1-have an intermediate metastatic capacity. The radiosensitivity in vitro of these clones and variants is related to their metastatic capacity in vivo (Table 1 and 2). More precisely, the proportion of radioresistant cells (X) in each subline is significantly related to their metastatic potential: the lower X is, the higher the metastatic potential (P < 0.006) ( Figure 4A ). This relationship is valid only as long as the radiation survival curves of the highly metastatic cells are biphasic, i.e. when these cells are cultured for no more than five passages. With additional passages in vitro (up to 15), the survival curves of the highly metastatic cells become monophasic and, as the proportion of radioresistant cells increases (Figure 2A ), the relationship with the metastatic potential loses its significance. Furthermore, when the radiosensitivity of the radioresistant clonal fraction (as estimated by theDR values in Table 2 ) is taken into account, there is no significant relationship with the metastatic potential given in Table 1 (P = 0.3, Figure  4B ). Moreover, the radiosensitivity of the radioresistant clonal fraction does not change with the passage level (see Figure 2 ).
British Journal of Cancer (1997) 75(5) Table 3 The metastatic potential of clone 4 cells that have received a priming dose of 2 Gy was compared with that of the control clone 4 cells that have not received the priming dose. In addition, the radiosensitivity of these cells was compared. The metastatic potential and radiosensitivity experiments were performed 24 h after the priming dose of 2 Gy. The cells have been cultured for no more than five passages before injection to the newborn rats and the passage number after cell defrost was the same for the control and the experimental group. As a working hypothesis, it was postulated that the metastatic potential of our clones and variants is a specific feature of their radiosensitive cell population. To test this hypothesis, both the radiosensitivity in vitro and the metastatic capacity of the clone 4 cells cultured for no more than five passages in vitro were measured after a priming dose of 2 Gy given 24 h before experiments -a procedure that should eliminate the radiosensitive cells. The results presented in Table 3 support the concept of the two populations, as the radiosensitivity of the cells that have received a priming dose of 2 Gy was lower than that obtained for the control cells that have not received the priming dose. Moreover, the metastatic potential in vivo of the cells that have received a priming dose of 2 Gy and injected subcutaneously 24 h after the irradiation in the immunosuppressed newborn rats is fivefold lower than that of the control cells that have not received the priming dose of 2 Gy (P = 0.035, t-test) (Table 3 ). This result clearly shows a decrease of the metastatic potential upon the disappearance of the radiosensitive population. Moreover, the separation by flow cytometry of the two populations in variant 1, selected for their high and low PNA-binding ability, showed that the higher the proportion of radiosensitive cells in each subpopulation, the higher their metastatic potential (Tables 1 and 2 and Figure 3) . We suggest therefore that the metastatic potential of the seven clones and variants derived from the M4Be cell line depends on the radiosensitive population. This proposal does not necessarily imply that metastases are more radiosensitive than the tumour of origin as the heterogeneity may quickly reappear in situ. Indeed, the characterized melanoma cells isolated from the lung metastasis were not significantly more radiosensitive than those isolated from the primary melanoma tumour (CP Thomas et al, unpublished results) . Although the latter result is consistent with those obtained by Rofstad (1992) , the data in this field are controversial. It was reported that small-size lung metastases irradiated in situ were more radiosensitive than the single cell suspensions obtained from the mammary tumour of origin and irradiated in vitro (Fu et al, 1976) . In vitro cell survival curves of the lung metastases were also determined (Welch et al, 1983) , and the survival curve obtained with a clone derived from an original subcutaneous mammary tumour was found to be triphasic. It can be noticed that the initial part of the latter survival curve, revealing a highly radiosensitive subpopulation of cells, is similar to the survival curve observed with the lung metastases. A similar behaviour regarding the radiosensitivity in vitro was detected recently with a human cell line established from an endometrial adenocarcinoma and a supraclavicular fossa metastasis originating from the same patient (Rantanen et al, 1995) .
In the present study, provided that the cells were cultured for no more than five passages in vitro, a significant relationship was defined between the radiosensitive cell fraction of the sublines derived from a single parental melanoma cell line and their metastatic potential. The radiosensitive cell fraction, which is important in the highly metastatic cells, is however rapidly lost over the time in culture. The causes of such transcients in the radiosensitivity of the highly metastatic cells remains unknown to us. A similar variabilty is also encountered with the metastatic incidence of the highly metastatic cells which for example in clone 4 is found to vary from 100% (Table 1) to 40% (Table 3) even though the experiments were conducted in similar conditions, with the cells being cultured for a short period in vitro. This is however not surprising as many technical factors are known to infuence the metastatic incidence, such as the level of immunosuppression achieved by ATS, the method of cell injection, etc. . It is remarkable that, despite all these factors of variability, we have been able to observe some significant correlations.
Our results suggest that a whole-body irradiation of metastatic tumour-bearing animals with a low dose of irradiation should result in a significant decrease of the metastatic cell population. Experiments were carried out to test this hypothesis. The data in Table 4 show that, when metastatic-melanoma-bearing newborn rats are whole-body irradiated with a dose of 20 cGy immediately after the cell injection, a suppression of the metastatic potential of the tumour occurs. Consistently with our results, it was observed that the number of artificial lung metastases of a murine squamous cell carcinoma is reduced about twofold when the mice are wholebody irradiated, immediately after the tumour cell injection, with a British Journal of Cancer (1997) 75(5), [639] [640] [641] [642] [643] [644] [645] [646] [647] [648] [649] dose of 20 cGy; although the effect was thought to result from a radiation-induced stimulation of the immune system (Hosoi and Sakamoto, 1993) . As the results on the hyper-radiosensitivity of the highly metastatic cells were obtained using a clonogenic assay, with the cells plated at low density and irradiated 24 h later, this phenomenon would be relevant in a clinical situation under the same experimental conditions. For example, this may be applicable in a situation where the metastatic cells are isolated either after escaping from the primary tumour or as soon as they start growing in a distant tissue.
On the one hand, in a recent review of the data from six centres, no relationship was found between the metastatic potential of 222 human carcinoma biopsies, 24 experimental tumours of various histology, 21 tumor cell lines and 16 sublines and their radiosensitivity (Suit et al, 1994) . On the other hand, in the present study within a single melanoma cell line, the metastatic potential of the clones and variants derived from the parental melanoma cell line was related to their proportion of radiosensitive cells, provided that the cells were cultured for no more than five passages in vitro after the defrost; this restrictive condition might account for the apparent discordance with previous studies as we have shown that the fraction of radiosensitive cells is progressively lost along with the passages in culture (Figure 2 ). If such a behaviour could be confirmed in other tumour cell lines, a unified view may be that the radiosensitivity of a given cell line containing only one major population (e.g. the parental M4Be cell line contains only a major radioresistant cell population) and the proportion of potentially radiosensitive cells within this cell line are independent parameters. This proportion of potentially radiosensitive cells, which is suggested to be responsible for the metastatic potential, varies at the clonal level within a given cell line and may vary from one cell line to another, whatever the radiosensitivity of the cell line. Thus, the radiosensitive cell lines may have a low metastatic potential, similar to the radioresistant ones, provided that the hyperradiosensitive subpopulation is not present in these cell lines. The deficiency in the surface gangliosides is a feature of the highly metastatic and highly radiosensitive human melanoma cells The total gangliosides content and the number of cells positively labelled with the monoclonal antibody directed to the surface disialoganglioside GD3 in the early confluent cultures obtained from the human melanoma cell line M4Be and the seven sublines derived from M4Be is shown in Table 1 . The lower the total amount of gangliosides, the higher the proportion of radiosensitive cells inside M4Be and its seven sublines ( Figure 5) . Also, the lower the number of GD3-positive cells in the early confluent cultures of M4Be and its seven sublines, the higher their proportion of radiosensitive cells ( Figure 5 ). Similar results regarding the number of GD3+ cells were obtained with the exponentially growing cells. Thus, it seems unlikely that the number of cells GD3+ depends on the proliferation rate in non-synchronized cultures. We propose that, inside the human melanoma cell line M4Be, the cells deficient in gangliosides are more metastatic and more radiosensitive than those rich in gangliosides. This hypothesis is strengthened by the experiments which show that the radioresistance of the M4Be cells could be modified by changing their gangliosides status ( Figure 6 ). ( Figure 6A ). Secondly, the incubation of the radiosensitive clone 4 with the exogeneous bovine brain monosialoganglioside GM 1 (4 gM) for 4 days significantly increases the proportion of radioresistant cells in vitro ( Figure 6B ) and suppresses the metastatic potential in vivo (Table 4) . The results are more extensively reported in two companion papers (Thomas et al, 1995b (Thomas et al, , 1996 . Thus, the decrease of the gangliosides expression at the cell surface may be involved in the metastatic potential of human melanoma tumours.
This proposal is strengthened by the published data from our laboratory showing that, after the subcutaneous injection of cells from the human melanoma clone 1 (poorly metastatic and high gangliosides content in vitro) and clone 4 (highly metastatic and low gangliosides content in vitro) in newborn rats, the tumour cells proliferating at the injection site re-expressed the four common gangliosides of melanoma (GM3, GM2, GD3 and GD2), whereas the metastatic lung colonies of clone 1 and 4 were deficient in the gangliosides synthesis (Zebda et al, 1995) . It seems that the cells with low gangliosides content inside these two sublines possess the highest ability to form lung metastases. Furthermore, our data show that the proportion of radioresistant cells (k) in the highly metastatic human melanoma clones derived from a single poorly metastatic parental cell line M4Be increased rapidly during the time in culture ( Figure  2 ). As we have established a correlation showing that the higher the value of X, the higher the gangliosides content (particularly GD3) at the cell surface of sublines derived from M4Be ( Figure 5 ), it is tempting to suggest that the increase of k over time in culture in the highly metastatic clones is associated with a parallel increase in the gangliosides synthesis (particularly GD3). Although no systematic study was designed to verify this hypothesis, we have observed during the time course of our experiments that the proportion of cells which are GD3 positive in the radiosensitive and metastatic clone 4 could vary from 1% to 20% and that this change is roughly associated with an increase in k. The reason(s) causing such transcients in the gangliosides expression at the surface of the radiosensitive and metastatic human melanoma cells is still unknown. The mechanism by which the change in the gangliosides status controlled the radiosensitive cell fraction and, hence, the metastatic potential is also unclear. We suggest that the electrostatic environment provided by the negatively charged sialic acid residues of the cell surface gangliosides may influence the radioresistant cell fraction as the cleaving with neuraminidase of more than 50% of these surface molecules significantly reduces X (Thomas et al, 1996) . These data support the postulate of Alper that, although DNA is usually considered as the main critical target for radiation, an additonal lethal effect may also be produced by the free-radicals that damage the cell membrane functions (Alper, 1979) . We wish to emphasize that these membrane effects may occur at low doses of radiation in the hyper-radiosensitive cells. In summary, the in vitro radiation cell-survival curves of the seven clones and variants derived from a human melanoma cell line differ essentially by the proportion of hyper-radiosensitive cells.
This cell population is rapidly lost over the time in culture. UsingDR as an index of the radiosensitivity, it was found that the radiosensitivity of the radioresistant fraction of the cell population, which is not drifting with the passages, is similar among the seven sublines and the parental line. Therefore,DR cannot be correlated with the metastatic potential. In the present study, a correlation was established between the metastatic potential and the hyper-radiosensitive fraction of the melanoma cells. Our data suggest that the metastatic potential of a cell line in vivo is due to the fraction of radiosensitive cells in vitro. A possible explanation for the correlation is provided in this study which shows that the change of the ganglioside status at the cell surface modifies the proportion of radiosensitive cells and hence, the metastatic potential of human melanoma.
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